Mr. Michael F. Mahoney is a Lead Independent Director at CVS Health Corp., a Member-CEO Roundatable at American Heart Association, Inc., a Chairman, President & Chief Executive Officer at Boston Scientific Corp., a Chairman-Governors Board at Boston College Ceo Club, a Chief Executive Officer at Boston Scientific Scimed, Inc., a Chief Executive Officer at EndoChoice, Inc., a Chief Executive Officer at Farapulse, Inc., a Chief Executive Officer at Vertiflex, Inc., a President at Boston Scientific Cardiac Diagnostics, Inc. (Texas), a President at Corvita Corp. and a President at Lumenis, Inc. He is on the Board of Directors at CVS Health Corp., Baxter Healthcare Ltd. (United Kingdom), AdvaMed Accel, Advanced Medical Technology Association, Baxter Healthcare Pty Ltd., Baxter SpA, Boys & Girls Club of Boston, VisionBank of Iowa and VisionBankshares, Inc. Mr. Mahoney was previously employed as an Independent Director by Baxter International, Inc., a Chairman-Worldwide Medical Devices & Diagnostics by Johnson & Johnson, a President & Chief Executive Officer by Global Healthcare Exchange LLC, a President by Augmenix, Inc., a Chief Executive Officer by CEO Roundtable LLC, a Chief Executive Officer by Cryterion Medical, Inc., a Worldwide Group Chairman by DePuy Orthopaedics, Inc., a General Manager-Healthcare Information Technology by GE Medical Systems, Inc., a Chief Executive Officer by IntElect Medical, Inc., and a Chief Executive Officer by IoGyn, Inc. He also served on the board at Baxter International, Inc. He received his undergraduate degree from the University of Iowa and an MBA from Wake Forest University.
Joseph M. Fitzgerald
Joseph M. Fitzgerald is Executive VP & Group President-Cardiology at Boston Scientific Corp. since 2022. Former roles include Director-Business Intelligence at Anheuser Busch, Inc., President at CryoCor, Inc., and Vice President-Global Marketing at NeuroVascular Recovery Ltd. from 1997 to 2005. Education includes undergraduate studies at Indiana University and an MBA from Southern Illinois University.
Michael F. Mahoney
Mr. Michael F. Mahoney is a Lead Independent Director at CVS Health Corp., a Member-CEO Roundatable at American Heart Association, Inc., a Chairman, President & Chief Executive Officer at Boston Scientific Corp., a Chairman-Governors Board at Boston College Ceo Club, a Chief Executive Officer at Boston Scientific Scimed, Inc., a Chief Executive Officer at EndoChoice, Inc., a Chief Executive Officer at Farapulse, Inc., a Chief Executive Officer at Vertiflex, Inc., a President at Boston Scientific Cardiac Diagnostics, Inc. (Texas), a President at Corvita Corp. and a President at Lumenis, Inc. He is on the Board of Directors at CVS Health Corp., Baxter Healthcare Ltd. (United Kingdom), AdvaMed Accel, Advanced Medical Technology Association, Baxter Healthcare Pty Ltd., Baxter SpA, Boys & Girls Club of Boston, VisionBank of Iowa and VisionBankshares, Inc. Mr. Mahoney was previously employed as an Independent Director by Baxter International, Inc., a Chairman-Worldwide Medical Devices & Diagnostics by Johnson & Johnson, a President & Chief Executive Officer by Global Healthcare Exchange LLC, a President by Augmenix, Inc., a Chief Executive Officer by CEO Roundtable LLC, a Chief Executive Officer by Cryterion Medical, Inc., a Worldwide Group Chairman by DePuy Orthopaedics, Inc., a General Manager-Healthcare Information Technology by GE Medical Systems, Inc., a Chief Executive Officer by IntElect Medical, Inc., and a Chief Executive Officer by IoGyn, Inc. He also served on the board at Baxter International, Inc. He received his undergraduate degree from the University of Iowa and an MBA from Wake Forest University.
Edward J. Ludwig
Edward J. Ludwig is currently Chairman at POCARED Diagnostics Ltd. since 2013, Chairman at GRIP Molecular Technologies, Inc. since 2021, Lead Independent Director at Boston Scientific Corp. since 2016, Director at Center For Higher Ambition, and Trustee at The Johns Hopkins University. Former roles include Chairman & Chief Executive Officer at Becton, Dickinson & Co. from 2008 to 2011, Vice Chairman at HMH Hospitals Corp, Inc. from 2013 to 2015, Independent Director at Aetna, Inc. from 2011 to 2014, Director at Advanced Medical Technology Association from 2006 to 2008, Independent Director at Xylem, Inc. from 2011 to 2017, Independent Director at CVS Health Corp. from 2018 to 2024, Trustee at College of the Holy Cross (Massachusetts) from 2005 to 2013, Senior Auditor at Coopers & Lybrand LLP, and Member-Overseers Board at Columbia Business School from 2010 to 2015. Education includes undergraduate degree from College of the Holy Cross (Massachusetts) and MBA from Columbia Business School.
Ellen M. Zane
Ellen M. Zane is President & Chief Executive Officer at The Floating Hospital, Inc. and Tufts Medical Center, Inc. since 2004. She is Chairman at Haemonetics Corp. since 2021, Chairman at Tufts Medicine, Inc., Chairman at Medical Faculty Associates, Inc., Vice Chairman at George Washington University, Independent Director at Boston Scientific Corp. since 2016, Independent Director at Synchrony Financial since 2016, Director at Massachusetts Development Finance Agency, Director at National Association of Corporate Directors, New England CH*, Director at AgNovos Healthcare LLC, Director at Fiduciary Co., Inc., Director at FinThrive, Inc. since 2018, Director at Savista LLC (Georgia), Director at Synchrony Bank since 2022, and Trustee at Newbridge on the Charles, Inc. Former positions include Chief Executive Officer at Quincy Hospital, President & Chief Executive Officer at Floating Hospital For Children from 2004 to 2011, Chairman at Massachusetts Health & Hospital Association, Inc. in 2010, Chairman at Minuteman Health, Inc., Independent Director at Lincare Holdings, Inc. from 2011 to 2012, Independent Director at Azenta, Inc. from 2012 to 2024, Director at PAREXEL International Corp. from 2015 to 2017, Independent Director at Haemonetics Corp. from 2012 to 2016, Director at Fiduciary Trust Co., Director at Variagenics, Inc., Director at Press Ganey Associates, Director at United Way of Massachusetts Bay & Merrimack Valley, Director at Century Capital Management, Inc., Director at MassDevelopment, Independent Director at Press Ganey Associates LLC from 2012 to 2016, Network President at Mass General Brigham, Inc. from 1994 to 2004, and Assistant Professor at Tufts University School of Medicine. Education includes an undergraduate degree from George Washington University conferred in 1973 and a graduate degree from The Catholic University of America conferred in 1975.
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
David Scott Wichmann
David Scott Wichmann currently serves as Independent Director at Boston Scientific Corp. since 2021, Director at Minnesota Orchestral Association, Director at Vytalize Health, Inc. since 2023, and Independent Director at Privia Health Group, Inc. since 2023. Former roles include Chief Executive Officer & Director at UnitedHealth Group, Inc. from 2017 to 2021, Chief Executive Officer-Specialized Care Services at OptumHealth, Inc. from 2004 to 2013, Chairman at Council for Affordable Quality Healthcare, Inc., Independent Director at Tennant Co., Partner at Arthur Andersen LLP from 1995 to 1998, CFO, President-Operations & Technology at UnitedHealthcare, Inc. in 2006, and Chief Financial Officer at Advance Machine Co. in 1994. Education includes undergraduate studies at Illinois State University.
Jessica L. Mega
Jessica L. Mega was the founder of Verily Life Sciences LLC, founded in 2015, where the title held was Chief Medical & Scientific Officer from 2015 to 2023. The current job is Independent Director at Boston Scientific Corp. starting in 2023. Former job includes Independent Director at Danaher Corp. from 2019 to 2026. Education history includes an undergraduate degree from Stanford University conferred in 1996, a graduate degree from Harvard T.H. Chan School of Public Health, and a doctorate from Yale School of Medicine.
Susan E. Morano
Susan E. Morano is currently an Independent Director at Boston Scientific Corp. since 2023. Former positions include Director-Clinical Operations at Cutanea Life Sciences, Inc., Senior Manager-Medical Affairs at Fibrocell Science, Inc. in 2005, Manager-Scientific Communications at Dermik Laboratories, Inc. in 2004, and VP-Business Development & Strategic Operations at Johnson & Johnson from 2020 to 2023. Education includes an undergraduate degree from Villanova University and an MBA from Columbia Business School.
Cheryl Pegus
Cheryl B. Pegus is currently Chairman & Chief Executive Officer at Intellihealth, Inc. starting in 2025. Dr. Pegus serves as Director at Zillion Group, Inc., American Heart Association, Inc., and Association of Black Cardiologists since 2018. Dr. Pegus is Independent Director at Boston Scientific Corp. and Concentra Group Holdings Parent, Inc. since 2024. Dr. Pegus is President-Consumer Health Solutions at Cambia Health Solutions, Inc. since 2020. Dr. Pegus is Member-Deans Circle at Weill Cornell Medical College and Professor-Medicine & Population Health at New York University School of Medicine. Former roles include Independent Director at Vision-Sciences, Inc. (2013–2014), Tactile Systems Technology, Inc. (2017–2020), Phreesia, Inc. (2019–2021), and Cogentix Medical, Inc. (2013–2018). Dr. Pegus was Director at Aseko, Inc., Ulta Salon, Cosmetics & Fragrance, Inc., Business Group on Health, Care Continuum Alliance, Glytec LLC, U.S. Acute Care Solutions LLC, and NYU Langone Health (Director-General Internal Medicine). Dr. Pegus was Medical Director-Cardiovascular Risk Factors Group at Pfizer Pharmaceuticals, Inc. Dr. Pegus was Chief Medical Officer at Walgreen Co. (2010–2013), Take Care Health Systems LLC, and Symcare Personalized Health Solutions, Inc. (2007–2010). Dr. Pegus was Head-Clinical Products at Aetna, Inc. (2003–2006). Dr. Pegus was President at Caluent LLC (2013–2020) and Executive Vice President-Health & Wellness at Walmart, Inc. (2020–2023). Education includes undergraduate degree from Brandeis University, doctorate from Weill Cornell Medical College, and graduate degree from Joseph L. Mailman School of Public Health.
David C. Habiger
Mr. David C. Habiger is a Chairman at Liftoff Mobile, Inc., an Independent Director at EnerSys, an Independent Director at Boston Scientific Corp., a Chairman at Reddit, Inc., a Chairman at Xperi, Inc., a Chairman at Legend3D, Inc., a Chief Executive Officer & Director at NDS Group Holdings Ltd., an Independent Director at Silicon Valley Leadership Group, a Member at Center for Corporate Innovation, Inc., a Member at National Association of Corporate Directors (Virginia) and a Member at Society of Motion Picture & Television Engineers. He is on the Board of Directors at EnerSys, Boston Scientific Corp., Sovos Compliance LLC, Federal Reserve Bank of Chicago, J.D. Power, NDS Group Holdings Ltd., Automotive Hall of Fame, Inc., Conviva, Inc., Rush University Medical Center, Sovos Co-Invest LP, Stampscom, Inc., Tessera, Inc., The Next New You and Silicon Valley Leadership Group. Mr. Habiger was previously employed as an Independent Director by Noble Rock Acquisition Corp., a Chairman by Xperi Holding Corp., a Chairman by Xperi Corp., an Independent Director by Auctane, Inc., an Independent Director by Grubhub, Inc., a Partner by Silicon Media Partners LLC, an Independent Director by Enova International, Inc., an Independent D
Catherine R. Smith
Catherine R. Smith currently works at PPG Industries, Inc., as Independent Director from 2019, Boston Scientific Corp., as Director from 2026, The Curtis L. Carlson School of Management, as Director, Baxter Healthcare Ltd. (United Kingdom), as Director from 2017, Baxter SpA, as Director from 2017, Baxter Healthcare Pty Ltd., as Director, and Starbucks Corp., as Chief Financial Officer & Executive Vice President from 2025. Ms. Smith also formerly worked at Wal-Mart de México SAB de CV, as Director from 2010 to 2014, Dick's Sporting Goods, Inc., as Director from 2009 to 2010, Baxter International, Inc., as Independent Director from 2017 to 2026, Centex Corp., as Chief Financial Officer & Executive Vice President in 2009, Kennametal, Inc., as Chief Financial Officer & Executive Vice President from 2005 to 2006, Raytheon Co., as CFO, VP-Intelligence & Information Systems in 2003, Textron, Inc., as Chief Financial Officer & EVP-Bell Systems from 2003 to 2005, Express Scripts, Inc., as Chief Financial Officer & Executive Vice President from 2014 to 2015, Target Corp., as Chief Financial Officer & Executive Vice President from 2015 to 2019, GameStop Corp., as Chief Financial Officer & Executive Vice President from 2009 to 2010, Evernorth Health, Inc., as Chief Financial Officer & Executive Vice President from 2014 to 2015, Wal-Mart International, as Chief Financial Officer & Executive Vice President from 2010 to 2014, Bell Textron, Inc., as Chief Financial Officer & Executive Vice President in 2009, NeueHealth, Inc., as Chief Financial & Administrative Officer from 2020 to 2023, and Nordstrom, Inc., as Chief Financial Officer, Treasurer & Executive VP from 2023 to 2025. Ms. Smith received her undergraduate degree from the University of California, Santa Barbara and Masters Business Admin degree from USC Marshall School of Business.
Christophe Weber
Dr. Christophe Weber is a President, CEO & Representative Director at Takeda Pharmaceutical Co., Ltd., an Advisor at Longwood Fund Management LLC and a President at Takeda Italia SpA. He is on the Board of Directors at Boston Scientific Corp. and Takeda Pharmaceutical Co., Ltd. Dr. Weber was previously employed as a President, Chief Executive Officer & Director by Millennium Pharmaceuticals, Inc., a Chief Executive Officer by GlaxoSmithKline Biologicals SA, a President & General Manager-Vaccines Division by GlaxoSmithKline Pharmaceuticals SA (Belgium), a Chairman & Chief Executive Officer by Groupe GlaxoSmithKline SAS, and a President & Chief Executive Officer by Takeda Pharmaceuticals (Asia Pacific) Pte Ltd. He received his undergraduate degree from Université Jean Moulin Lyon 3, a graduate degree from Universite Lumiere Lyon 2, a graduate degree from the University of Lyon and a doctorate degree from the University of Lyon.
提供，免责声明：天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性，但对于其正确性或可靠性则不予担保，且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。